327 related articles for article (PubMed ID: 17661407)
21. Hepatic stellate cells in inflammation-fibrosis-carcinoma axis.
Wang BB; Cheng JY; Gao HH; Zhang Y; Chen ZN; Bian H
Anat Rec (Hoboken); 2010 Sep; 293(9):1492-6. PubMed ID: 20652939
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the role of nuclear factor-kappaB signaling in liver injury using genetic animal models.
Luedde T; Beraza N; Trautwein C
J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S43-6. PubMed ID: 16958671
[TBL] [Abstract][Full Text] [Related]
23. The two-faced NF-kappaB in the skin.
Sur I; Ulvmar M; Toftgård R
Int Rev Immunol; 2008; 27(4):205-23. PubMed ID: 18574737
[TBL] [Abstract][Full Text] [Related]
24. NF-kappaB signaling, liver disease and hepatoprotective agents.
Sun B; Karin M
Oncogene; 2008 Oct; 27(48):6228-44. PubMed ID: 18931690
[TBL] [Abstract][Full Text] [Related]
25. Hypoxic regulation of NF-kappaB signaling.
Cummins EP; Comerford KM; Scholz C; Bruning U; Taylor CT
Methods Enzymol; 2007; 435():479-92. PubMed ID: 17998070
[TBL] [Abstract][Full Text] [Related]
26. NF-kappaB signaling pathway and its therapeutic implications in human diseases.
Sarkar FH; Li Y; Wang Z; Kong D
Int Rev Immunol; 2008; 27(5):293-319. PubMed ID: 18853341
[TBL] [Abstract][Full Text] [Related]
27. Is nuclear factor kappa-B the missing link between inflammation, cancer and alteration in hepatic drug metabolism in patients with cancer?
Assenat E; Gerbal-chaloin S; Maurel P; Vilarem MJ; Pascussi JM
Eur J Cancer; 2006 Apr; 42(6):785-92. PubMed ID: 16510279
[TBL] [Abstract][Full Text] [Related]
28. Inflammation and liver cancer: new molecular links .
Berasain C; Castillo J; Perugorria MJ; Latasa MU; Prieto J; Avila MA
Ann N Y Acad Sci; 2009 Feb; 1155():206-21. PubMed ID: 19250206
[TBL] [Abstract][Full Text] [Related]
29. Invasion associated up-regulation of nuclear factor kappaB target genes in colorectal cancer.
Horst D; Budczies J; Brabletz T; Kirchner T; Hlubek F
Cancer; 2009 Nov; 115(21):4946-58. PubMed ID: 19658179
[TBL] [Abstract][Full Text] [Related]
30. Anti-inflammatory interventions of NF-kappaB signaling: potential applications and risks.
Uwe S
Biochem Pharmacol; 2008 Apr; 75(8):1567-79. PubMed ID: 18070616
[TBL] [Abstract][Full Text] [Related]
31. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory tales of liver cancer.
Hoffmann A; Xia Y; Verma IM
Cancer Cell; 2007 Feb; 11(2):99-101. PubMed ID: 17292819
[TBL] [Abstract][Full Text] [Related]
33. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death.
Lluis JM; Buricchi F; Chiarugi P; Morales A; Fernandez-Checa JC
Cancer Res; 2007 Aug; 67(15):7368-77. PubMed ID: 17671207
[TBL] [Abstract][Full Text] [Related]
34. A gut feeling of the PXR, PPAR and NF-kappaB connection.
Wahli W
J Intern Med; 2008 Jun; 263(6):613-9. PubMed ID: 18479261
[TBL] [Abstract][Full Text] [Related]
35. Nuclear factor kappaB and hepatitis C--Is there a connection?
Yen TS
Hepatology; 2000 Mar; 31(3):785-7. PubMed ID: 10706574
[No Abstract] [Full Text] [Related]
36. Transcription factor NF-kappaB regulation of renal fibrosis during ureteral obstruction.
Morrissey J; Klahr S
Semin Nephrol; 1998 Nov; 18(6):603-11. PubMed ID: 9819151
[TBL] [Abstract][Full Text] [Related]
37. NF-κB in liver cancer: the plot thickens.
Finkin S; Pikarsky E
Curr Top Microbiol Immunol; 2011; 349():185-96. PubMed ID: 20857271
[TBL] [Abstract][Full Text] [Related]
38. Skeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention.
Peterson JM; Guttridge DC
Int Rev Immunol; 2008; 27(5):375-87. PubMed ID: 18853344
[TBL] [Abstract][Full Text] [Related]
39. G protein-coupled receptor connectivity to NF-kappaB in inflammation and cancer.
Fraser CC
Int Rev Immunol; 2008; 27(5):320-50. PubMed ID: 18853342
[TBL] [Abstract][Full Text] [Related]
40. NF-kappaB inhibition: a double-edged sword in cancer?
Pikarsky E; Ben-Neriah Y
Eur J Cancer; 2006 Apr; 42(6):779-84. PubMed ID: 16530406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
